Full name
"FELIX PHARMA LABORATORIUM GALENOWE ZAKŁAD PRODUKCYJNY" - SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"FELIX PHARMA LABORATORIUM GALENOWE ZAKŁAD PRODUKCYJNY" - SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
KOL. DĘBÓWKA 17 "D", 20-823 KOL. DĘBÓWKA
TAX ID7120157765
Rate company:
"FELIX PHARMA LABORATORIUM GALENOWE ZAKŁAD PRODUKCYJNY" - SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7120157765
KRS0000253090
Share capital474,000.00 zł
address
KOL. DĘBÓWKA 17 "D", 20-823 KOL. DĘBÓWKA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7120157765
REGON
430023347
KRS
0000253090
Legal form
limited liability company
Register Address
KOL. DĘBÓWKA 17 "D", 20-823 KOL. DĘBÓWKA
Date of registration in KRS
2006-03-21
Date of commencement of economic activity
2006-03-21
Act signature
LU.VI NS-REJ.KRS/2317/25/590
Pkd codes
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.89.A - Production of dietary supplements
20.42.Z - Manufacture of cosmetics and toilet preparations
46.46.Z - Wholesale trade of pharmaceutical and medical products
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale  | -0,2 | -0,2 | -0,1 | 55,9 |
Gross profit (loss) | -0,2 | 0,3 | -0,1 | -137,5 |
EBITDA | -0,2 | 0,3 | -0,1 | -137,5 |
Short time liabilities | 102,7 | 102,3 | 102,3 | 0 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | -96,5 | -96,3 | -96,4 | -0,1 |
Operating profit (EBIT) | -0,2 | 0,3 | -0,1 | -137,5 |
Assets | 6,1 | 6,1 | 6 | -1,6 |
Net profit (loss) | -0,2 | 0,3 | -0,1 | -137,5 |
Cash | 0 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 102,7 | 102,3 | 102,3 | 0 |
Working assets | 6,1 | 6,1 | 6 | -1,6 |
Other income costs | 0 | 0,5 | 0 | -100 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 0,2 | -0,3 | 0,1 | 0,4 |
Equity capital to total assets | -1576,5 | -1585,1 | -1613,3 | -28,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.05964687094092369 | 0.059342965483665466 | 0.05836578086018562 | 0 |
Net dept to EBITDA | -1.5532351732254028 | 0 | 0 | 0 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Interton.pl sp. z o.o.
Kraków
NTRADE
Marcinowice
Bardomed sp. z o.o.
Kraków
Mi-Ro S.C.
Stróża
Przedsiębiorstwo Trans-Med
Zawiercie
"MEDILAB" sp. z o.o.
Warszawa